0001209191-24-003437.txt : 20240216
0001209191-24-003437.hdr.sgml : 20240216
20240216160012
ACCESSION NUMBER: 0001209191-24-003437
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: George Jean
CENTRAL INDEX KEY: 0001291804
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40499
FILM NUMBER: 24648143
MAIL ADDRESS:
STREET 1: CRITICAL THERAPEUTICS INC
STREET 2: 60 WESTVIEW STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662244
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 455429901
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: BUILDING B, SUITE 450
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 857-285-4140
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: BUILDING B, SUITE 450
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-14
0
0001662244
Cyteir Therapeutics, Inc.
CYT
0001291804
George Jean
C/O CYTEIR THERAPEUTICS, INC.
99 HAYDEN AVE, BUILDING B, SUITE 450
LEXINGTON
MA
02421
1
0
0
0
0
Common Stock
2024-02-14
4
M
0
14150
1.69
A
14150
D
Common Stock
2444265
I
See Footnote
Stock Option (Right to Buy)
1.69
2024-02-14
4
M
0
14150
0.00
D
2024-02-03
2033-02-03
Common Stock
14150
0
D
Shares held by Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. LSV Associates II, LLC is the general partner of Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. The Reporting Person is a managing director of LSV Associates II, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of her pecuniary interest therein.
/s/ David Gaiero, as attorney-in-fact for Jean George
2024-02-16